v3.26.1
Variable Interest Entities (VIEs)
6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Variable Interest Entities (VIEs)
15.
Variable Interest Entities (“VIEs”)

The Company’s condensed consolidated financial statements include its subsidiaries and consolidated VIEs. A VIE is defined as a legal entity whose equity owners lack sufficient equity at risk or, as a group, lack decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is the variable interest holder with both (i) the power to direct the activities most significantly affecting the VIE’s economic performance and (ii) the obligation to absorb expected losses or the right to receive benefits potentially significant to the VIE.

Certain states prohibit non-physician owned entities from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions (“corporate practice of medicine” laws). To comply with these laws, the Company maintains long-term MSAs with its affiliated IPAs and medical groups that are owned and operated solely by physicians. AHM, a wholly owned subsidiary, has entered into MSAs with several affiliated IPAs, including APC. APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board, to direct the activities (excluding clinical decisions) that most significantly affect APC’s economic performance. Accordingly, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying condensed consolidated financial statements.

Certain state laws also prohibit a multi-shareholder professional corporation from holding shares in another professional corporation; however, a single-shareholder professional corporation may do so. In reliance on this exception, the Company designated certain key personnel as the nominee shareholder of professional corporations that hold controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder, the Company retains the right to designate alternative equity holders. These entities are also managed by the Company’s wholly owned MSOs via MSAs and are consolidated in the accompanying condensed consolidated financial statements.

The following table presents assets that may only be used to settle VIE obligations, to which the creditors of Astrana have no recourse, and liabilities for which the creditors of the Company’s VIEs have no recourse to the general credit of Astrana. These assets and liabilities of the Company’s VIEs, with the exception of investments in affiliates and amounts due to, or from, affiliates, which are eliminated upon consolidation, are included in the accompanying condensed consolidated balance sheets (in thousands).

 

June 30, 2026

 

 

December 31, 2025

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

199,454

 

 

$

202,164

 

Receivables, net (including amounts from related parties)

 

 

195,449

 

 

 

208,929

 

Other receivables

 

 

11,387

 

 

 

8,907

 

Prepaid expenses and other current assets

 

 

10,946

 

 

 

12,946

 

Loans receivable

 

 

762

 

 

 

753

 

Amount due from affiliates (1)

 

 

25,050

 

 

 

58,265

 

 

 

 

 

 

 

 

Total current assets

 

 

443,048

 

 

 

491,964

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

Property and equipment, net

 

 

44,192

 

 

 

41,646

 

Intangible assets, net

 

 

195,368

 

 

 

216,594

 

Goodwill

 

 

545,674

 

 

 

524,751

 

Income taxes receivable, net of current portion

 

 

12,405

 

 

 

12,405

 

Loans receivable, net of current portion

 

 

111

 

 

 

194

 

Investments in other entities – equity method

 

 

18,355

 

 

 

17,069

 

Investment in affiliates (1)

 

 

284,623

 

 

 

152,155

 

Operating lease right-of-use assets

 

 

29,687

 

 

 

26,499

 

Other assets

 

 

5,154

 

 

 

3,692

 

 

 

 

 

 

 

 

Total non-current assets

 

 

1,135,569

 

 

 

995,005

 

 

 

 

 

 

 

 

Total assets

 

$

1,578,617

 

 

$

1,486,969

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

127,107

 

 

$

108,309

 

Fiduciary accounts payable

 

 

3,771

 

 

 

3,524

 

Medical liabilities

 

 

173,017

 

 

 

198,919

 

Income tax payable

 

 

16,145

 

 

 

15,007

 

Operating lease liabilities

 

 

6,426

 

 

 

5,473

 

Other liabilities

 

 

4,601

 

 

 

6,505

 

 

 

 

 

 

 

 

Total current liabilities

 

 

331,067

 

 

 

337,737

 

 

June 30, 2026

 

 

December 31, 2025

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

Deferred tax liability

 

 

7,418

 

 

 

7,159

 

Operating lease liabilities, net of current portion

 

 

26,571

 

 

 

24,241

 

Other long-term liabilities

 

 

1,832

 

 

 

6,855

 

 

 

 

 

 

 

 

Total non-current liabilities

 

 

35,821

 

 

 

38,255

 

 

 

 

 

 

 

 

Total liabilities

 

$

366,888

 

 

$

375,992

 

(1)
Investment in affiliates includes APC’s investment in Astrana. While such shares of Astrana’s common stock are legally issued to APC and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the accompanying condensed consolidated financial statements. Amounts due to, or from, affiliates are receivables or payables with Astrana’s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana’s condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025.